KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Interest & Investment Income (2023 - 2025)

Neogenomics (NEO) has disclosed Interest & Investment Income for 5 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest & Investment Income fell 64.81% year-over-year to $1.5 million, compared with a TTM value of $9.1 million through Dec 2025, down 50.78%, and an annual FY2025 reading of $9.1 million, down 50.78% over the prior year.
  • Interest & Investment Income was $1.5 million for Q4 2025 at Neogenomics, down from $1.6 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $4.8 million in Q4 2023 and bottomed at $1.5 million in Q4 2025.
  • Average Interest & Investment Income over 3 years is $3.7 million, with a median of $4.3 million recorded in 2023.
  • The sharpest move saw Interest & Investment Income increased 6.59% in 2024, then tumbled 66.55% in 2025.
  • Year by year, Interest & Investment Income stood at $4.8 million in 2023, then decreased by 10.67% to $4.3 million in 2024, then tumbled by 64.81% to $1.5 million in 2025.
  • Business Quant data shows Interest & Investment Income for NEO at $1.5 million in Q4 2025, $1.6 million in Q3 2025, and $2.3 million in Q2 2025.